Literature DB >> 22721918

Dissecting negative regulation of Toll-like receptor signaling.

Takeshi Kondo1, Taro Kawai, Shizuo Akira.   

Abstract

Toll-like receptors (TLRs) sense invading microbial pathogens and play crucial roles in the activation of innate and adaptive immunity. However, excessive TLR activation can disrupt immune homeostasis, and may be responsible for the development of autoimmune and inflammatory diseases. As such, the molecules and pathways that negatively control TLR signaling have been intensively investigated. Here, we discuss recent insights into the negative regulation of TLR signaling, with focus on three major mechanisms: (i) dissociation of adaptor complexes; (ii) degradation of signal proteins; and (iii) transcriptional regulation. We also highlight how pathogens negatively target TLR signaling as a strategy to evade the host immune response.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22721918     DOI: 10.1016/j.it.2012.05.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  186 in total

1.  Extracellular calcium elicits feedforward regulation of the Toll-like receptor-triggered innate immune response.

Authors:  Songqing Tang; Taoyong Chen; Mingjin Yang; Lei Wang; Zhou Yu; Bin Xie; Cheng Qian; Sheng Xu; Nan Li; Xuetao Cao; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 2.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

3.  sNASP inhibits TLR signaling to regulate immune response in sepsis.

Authors:  Feng-Ming Yang; Yong Zuo; Wei Zhou; Chuan Xia; Bumsuk Hahm; Mark Sullivan; Jinke Cheng; Hui-Ming Chang; Edward Th Yeh
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

4.  Presenilin 2 influences miR146 level and activity in microglia.

Authors:  Suman Jayadev; Amanda Case; Betty Alajajian; Alison J Eastman; Thomas Möller; Gwenn A Garden
Journal:  J Neurochem       Date:  2013-09-30       Impact factor: 5.372

5.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

6.  Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9.

Authors:  Zachary R Newman; Janet M Young; Nicholas T Ingolia; Gregory M Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

7.  Aspartate attenuates intestinal injury and inhibits TLR4 and NODs/NF-κB and p38 signaling in weaned pigs after LPS challenge.

Authors:  Haibo Wang; Yulan Liu; Haifeng Shi; Xiuying Wang; Huiling Zhu; Dingan Pi; Weibo Leng; Shuang Li
Journal:  Eur J Nutr       Date:  2016-02-23       Impact factor: 5.614

8.  Differential induction of inflammatory cytokines and reactive oxygen species in murine peritoneal macrophages and resident fresh bone marrow cells by acute staphylococcus aureus infection: contribution of toll-like receptor 2 (TLR2).

Authors:  Ajeya Nandi; Somrita Dey; Julie Biswas; Pooja Jaiswal; Shamreen Naaz; Tamima Yasmin; Biswadev Bishayi
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 9.  Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons.

Authors:  Hsin-Yu Liu; Chiung-Ya Chen; Yi-Ping Hsueh
Journal:  Neurosci Bull       Date:  2014-07-04       Impact factor: 5.203

Review 10.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.